Gregory Jones
6PUBLICATIONS
41CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 14, 2026
Generic Protocols for Analytical Validation of Tumor-Informed Circulating Tumor DNA Assays for Molecular Residual Disease: The Blood Profiling Atlas in Cancer's Molecular Residual Disease Analytical Validation Working Group Consensus Recommendation.Jonathan Baden, Cheng-Ho Jimmy Lin, Andrew T Anfora
|May 11, 2024
Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages.Brittany A McKelvey, Hillary S Andrews, Frederick L Baehner
|May 10, 2024
Author Correction: Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue
|Mar 28, 2024
Adjuvant nivolumab, capecitabine or the combination in patients with residual triple-negative breast cancer: the OXEL randomized phase II study.Filipa Lynce, Candace Mainor, Renee N Donahue
|Jun 12, 2020
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.Jordi Remon, Aurelie Swalduz, David Planchard
|Dec 06, 2018
<i>MGMT</i> Promoter Methylation Cutoff with Safety Margin for Selecting Glioblastoma Patients into Trials Omitting Temozolomide: A Pooled Analysis of Four Clinical Trials.Monika E Hegi, Els Genbrugge, Thierry Gorlia
Pageof 1
Frequent Collaborators
2 joint publications
Rita Nanda
2 joint publications
Christopher Gallagher
2 joint publications
Jay Zeck
2 joint publications
Filipa Lynce
2 joint publications
Candace Mainor
2 joint publications
Renee N Donahue
2 joint publications
Xue Geng
2 joint publications
Ilana Schlam
2 joint publications
Caroline Jochems
2 joint publications
Jeffrey Schlom
